Please use this identifier to cite or link to this item:
Title: Analgesic Efficacy and Safety of Tapentadol Immediate Release in Bunionectomy: A Meta-Analysis
Authors: Franco de la Torre, Lorenzo
Gómez Sánchez, Eduardo
Aragón Martínez, Othoniel Hugo
Hernández Gómez, Adriana
Franco González, Diana Laura
Guzmán Flores, Juan Manuel
Alonso Castro, Ángel Josabad
Granados Soto, Vinicio
Isiordia Espinoza, Mario Alberto
Keywords: tapentadol
hallux valgus surgery
pain control
adverse effects
Issue Date: Sep-2023
Publisher: MDPI
Citation: Franco-de la Torre, L.; Gómez-Sánchez, E.; Aragon-Martinez, O.H.; Hernández-Gómez, A.; Franco-González, D.L.; Guzmán-Flores, J.M.; Alonso-Castro, A.J.; Granados-Soto, V.; Isiordia-Espinoza, M.A. Analgesic Efficacy and Safety of Tapentadol Immediate Release in Bunionectomy: A Meta-Analysis. Pharmaceuticals 2023, 16, 1287.
Series/Report no.: Pharmaceuticals;2023, 16(9), 1287;
Abstract: The aim of this systematic review and meta-analysis was to evaluate the analgesic effect of different doses of tapentadol immediate release (IR) and its adverse effects after a bunionectomy. Pubmed, Cochrane, Lilacs, Medline, and Imbiomed were used to identify abstracts of scientific publications related to the keywords of this systematic review (PROSPERO ID CRD42023437295). Moreover, the risk of bias in all included articles was assessed using the Cochrane Collaboration risk of bias tool. Data on the sum of pain intensity, total pain relief, global assessment, and adverse effects were extracted. The statistical method of inverse variance with means difference was used to evaluate the numerical data and the Mantel–Haenszel and Odd Ratio test to analyze the dichotomous data. In addition, the number needed to treat, the number needed to harm, and the 95% confidence intervals were calculated. A qualitative evaluation (n = 2381) was carried out according to the conclusions of the authors. Tapentadol (n = 1772) was more effective in relieving postoperative pain than the placebo (n = 609) after a bunionectomy. In addition, the analgesic efficacy of IR tapentadol (n = 1323) versus the placebo (n = 390) was evaluated in a total of 1713 patients using a global evaluation of the treatments. All three doses of IR tapentadol showed better results compared to the placebo after a bunionectomy. Finally, the adverse effects have a direct relationship with the dose, and the greatest number of adverse effects are most observed with tapentadol IR 100 mg (n = 2381). It is concluded that tapentadol IR (100 mg) leads to the best satisfaction score in this meta-analysis.
Description: Artículo
ISSN: 1424-8247
Appears in Collections:3209 Artículos

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.